Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “STDs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06136702
What this trial is testing

ELEVATE Acceptability Study

Who this might be right for
Cervical CancerHPV InfectionAcceptability of Health Care
University Ghent 1,048
Post-approval studies (Phase 4)UnknownNCT03017872
What this trial is testing

Dolutegravir and Darunavir Evaluation in Adults Failing Therapy

Who this might be right for
HIV Infections
Kirby Institute 831
Large-scale testing (Phase 3)Active Not RecruitingNCT04176172
What this trial is testing

Optimizing Tobacco Use Treatment for PLWHA

Who this might be right for
HIV/AIDSNicotine Dependence
Abramson Cancer Center at Penn Medicine 340
Not applicableLooking for participantsNCT06860945
What this trial is testing

Development of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in Spain

Who this might be right for
Sexually Transmitted Infections (STIs)HIVPrEP
Hospital Universitario de Valme 9,000
Early research (Phase 1)Study completedNCT00001445
What this trial is testing

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 32
Early research (Phase 1)Study completedNCT00117429
What this trial is testing

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
Marcus Altfeld, M.D., Ph.D. 20
Large-scale testing (Phase 3)Study completedNCT00177437
What this trial is testing

Home Screening for Chlamydia Surveillance

Who this might be right for
Chlamydia TrachomatisGonorrhea
University of Pittsburgh 403
Early research (Phase 1)Study completedNCT00001053
What this trial is testing

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT03929172
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects

Who this might be right for
Papillomavirus Infections
2A Pharma AB 20
Testing effectiveness (Phase 2)WithdrawnNCT02462772
What this trial is testing

Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa

Who this might be right for
Human Immunodeficiency Virus
Centre for the AIDS Programme of Research in South Africa
Testing effectiveness (Phase 2)Study completedNCT00000851
What this trial is testing

Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 198
Early research (Phase 1)Study completedNCT00000887
What this trial is testing

Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00001993
What this trial is testing

Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3

Who this might be right for
HIV Infections
G D Searle 120
Not applicableStudy completedNCT02276521
What this trial is testing

Evaluation of Long Term Immunity Following HPV Vaccination

Who this might be right for
Cervical CancerAnogenital Warts
Murdoch Childrens Research Institute 200
Not applicableStudy completedNCT00183287
What this trial is testing

Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical Trials

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 150
Post-approval studies (Phase 4)Ended earlyNCT01676363
What this trial is testing

Pilot Study of Diflunisal in HIV-infected Adults

Who this might be right for
HIV Infection
University of British Columbia 8
Post-approval studies (Phase 4)Study completedNCT00924898
What this trial is testing

Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)

Who this might be right for
Acute HIV InfectionHIV Infections
University of North Carolina, Chapel Hill 92
Not applicableStudy completedNCT01231763
What this trial is testing

Acceptability Study of Vaginal Films for HIV Prevention

Who this might be right for
HIV InfectionsAnti-Infective Agents
University of Pittsburgh 84
Early research (Phase 1)Study completedNCT00482963
What this trial is testing

The Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication

Who this might be right for
HIV InfectionsContraceptionPharmacokinetics
University of Colorado, Denver 24
Not applicableStudy completedNCT05938621
What this trial is testing

Estamos Juntos (We Are Together): Improving HIV Care Delivery by Capacitating Health Care Providers

Who this might be right for
Hiv
Vanderbilt University Medical Center 28,448
Next Page